Concepedia

Greg Friberg

GF

Statistics

Publications

11

Citations

669

H-Index

11

Active since

2006

Affiliations

Amgen (United States)(Current)

The University of Texas MD Anderson Cancer Center

University of California San Diego

Greg Friberg is an author at Amgen (United States) specializing in immunotherapy, immunology, and medicine.

Top concepts

Publications per year

2006–2022

11

Publications

11

Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1

Anthony W. Tolcher, John Sarantopoulos, Amita Patnaik et al. · Journal of Clinical Oncology · 2009 · 307 citations

A First-in-Human Study of Conatumumab in Adult Patients with Advanced Solid Tumors

Roy S. Herbst, Razelle Kurzrock, David S. Hong et al. · Clinical Cancer Research · 2010 · 136 citations

Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs

Simon Eschweiler, Ciro Ramírez-Suástegui, Yingcong Li et al. · Nature · 2022 · 79 citations · Full text

Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusion

Gini F. Fleming, L. Philip Schumm, Greg Friberg et al. · BMC Cancer · 2015 · 27 citations · Full text

Blinatumomab (Blincyto): lessons learned from the bispecific t-cell engager (BiTE) in acute lymphocytic leukemia (ALL)

Greg Friberg, David Reese · Annals of Oncology · 2017 · 26 citations · Full text

, , +9

1–5 of 11